These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6893175

  • 21. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH, Goldstein DA, Massry SG.
    Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
    [No Abstract] [Full Text] [Related]

  • 22. Vitamin D-resistant rickets and 25-hydroxycholecalciferol.
    Manis J, Norman A.
    Br Med J; 1975 May 31; 2(5969):478-9. PubMed ID: 167901
    [No Abstract] [Full Text] [Related]

  • 23. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH, Marie PJ, Pettifor JM, Delvin EE.
    N Engl J Med; 1980 Oct 30; 303(18):1023-31. PubMed ID: 6252463
    [Abstract] [Full Text] [Related]

  • 24. Fanconi syndrome following bowel surgery and hepatitis reversed by 25-hydroxycholecalciferol.
    Chesney RW, Harrison HE.
    J Pediatr; 1975 Jun 30; 86(6):857-61. PubMed ID: 1127525
    [Abstract] [Full Text] [Related]

  • 25. Vitamin D metabolite concentrations in vitamin D deficiency. Are calcitriol levels normal.
    Chesney RW, Zimmerman J, Hamstra A, DeLuca HF, Mazees RB.
    Am J Dis Child; 1981 Nov 30; 135(11):1025-8. PubMed ID: 6271009
    [Abstract] [Full Text] [Related]

  • 26. [A sporadic case of vitamin D-resistant rickets in an adult].
    Chiesa A, Barbera G, Scassa E.
    Minerva Med; 1983 Feb 18; 74(6):255-60. PubMed ID: 6298662
    [Abstract] [Full Text] [Related]

  • 27. X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization.
    Costa T, Marie PJ, Scriver CR, Cole DE, Reade TM, Nogrady B, Glorieux FH, Delvin EE.
    J Clin Endocrinol Metab; 1981 Mar 18; 52(3):463-72. PubMed ID: 6893992
    [Abstract] [Full Text] [Related]

  • 28. An evaluation of 1 alpha-hydroxy-and 1,25-dihydroxyvitamin D3 in the treatment of renal bone disease.
    Kanis JA, Russell RG, Cundy T, Earnshaw M, Woods CG, Smith R, Heynen G.
    Contrib Nephrol; 1980 Mar 18; 18():12-28. PubMed ID: 7353370
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Elevated serum 1,25-dihydroxyvitamin D concentrations in siblings with primary Fanconi's syndrome.
    Tieder M, Arie R, Modai D, Samuel R, Weissgarten J, Liberman UA.
    N Engl J Med; 1988 Sep 29; 319(13):845-9. PubMed ID: 2842681
    [No Abstract] [Full Text] [Related]

  • 33. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L, Clayton PE, Brain C, Pelekouda E, Addison GM, Price DA, Mughal MZ.
    Clin Endocrinol (Oxf); 1996 Jun 29; 44(6):687-96. PubMed ID: 8759181
    [Abstract] [Full Text] [Related]

  • 34. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
    Gonzalez-Villapando C, Porath A, Berelowitz M, Marshall L, Favus MJ.
    J Clin Endocrinol Metab; 1980 Nov 29; 51(5):1180-3. PubMed ID: 6893459
    [Abstract] [Full Text] [Related]

  • 35. Effect of phenytoin on bone and vitamin D metabolism.
    Bell RD, Pak CY, Zerwekh J, Barilla DE, Vasko M.
    Ann Neurol; 1979 Apr 29; 5(4):374-8. PubMed ID: 220903
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N, Catto GR, Edward N, Fraser RA, O'Riordan JL, Papapoulos SE, Adami S.
    Proc Eur Dial Transplant Assoc; 1980 Apr 29; 17():543-7. PubMed ID: 6972529
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.
    Coburn JW, Brickman AS.
    Adv Exp Med Biol; 1978 Apr 29; 103():473-86. PubMed ID: 362852
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.